1ANT - JenaLib

Asymmetric/Biological Unit (84, 161)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I/L	M	20	T
02	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	21	F
03	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I/L	R	24	C
04	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	C
05	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I/L	R	47	H
06	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I/L	R	47	S
07	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I/L	R	57	C
08	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	58	L
09	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	C
10	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	63	S
11	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	66	P
12	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	80	T
13	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	89	K
14	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	93	D
15	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I/L	C	95	R
16	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I/L	L	99	F
17	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	99	V
18	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	Q	101	K
19	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I/L	K	114	E
20	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I/L	T	115	A
21	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I/L	S	116	P
22	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I/L	Q	118	P
23	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	120	Y
24	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	126	P
25	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	128	Y
26	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I/L	R	129	Q
27	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I/L	N	135	T
28	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	138	P
29	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	146	H
30	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	147	L
31	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I/L	Y	158	C
32	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	C
33	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	Y	166	H
34	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	182	F
35	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I/L	S	182	Y
36	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	186	N
37	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I/L	N	187	D
38	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	N	187	K
39	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I/L	S	191	P
40	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	T	211	I
41	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	V	216	G
42	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	219	T
43	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	W	225	R
44	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I/L	F	229	L
45	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I/L	E	237	K
46	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	I
47	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I/L	M	251	V
48	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	261	P
49	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	270	P
50	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	284	N
51	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	291	P
52	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I/L	E	302	K
53	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I/L	S	349	P
54	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I/L	R	359	Q
55	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	S	365	P
56	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I/L	D	366	H
57	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	H	369	R
58	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	L	S	380	R
59	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	L	A	382	T
60	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I/L	A	384	P
61	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I/L	A	384	S
62	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I/L	A	387	V
63	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I/L	G	392	D
64	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I/L	R	393	C
65	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	H
66	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I/L	R	393	P
67	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I/L	S	394	L
68	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
69	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
70	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
71	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
72	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	405	K
73	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	G
74	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	406	M
75	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	A
76	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I/L	P	407	L
77	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	P	407	T
78	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I/L	L	409	P
79	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	I	421	T
80	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I/L	G	424	R
81	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I/L	R	425	T
82	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I/L	A	427	D
83	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I/L	P	429	L
84	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I/L	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (1, 2)

Exons (6, 12)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain I from PDB  Type:PROTEIN  Length:402
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:420
                                    54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464
           ANT3_HUMAN    45 RDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d1anti_ I: Antith             rombin                                                                                                                                                                                                                                                                                                                                                                                                 SCOP domains
               CATH domains 1antI02 I:13-224,             I:321-377 Antithrombin, subunit I, domain 2                                                                                                                                           1antI01 I:225-320,I:383-432 Alpha-1-antitrypsin, domain 1                                       1antI02 I:13-224,I:321-377                                    1antI01 I:225-320,I:383-432                        CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .................-------------....hhhhhhhhhhhhhhhhhhhhhhh..........hhhhhhhhhhhhhh...hhhhhhhhhh.........hhhhhhhhhhhhhhhhh.....eeeeeeeeeee.......hhhhhhhh....eeeeee.....hhhhhhhhhhhhhhhh..................eeeeeeeeeeee..........eeeeeee....eeeeeeeeee.....................................hhhhhh..hhhhhhhhhh......eeee..eeeeeee..hhhhhhh...........................eeeeeeeeeee.-----...eeeeee........eeeee............................ Sec.struct. author
             SAPs(SNPs) (1) -------TF--C----------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R--------------P--V----DCL-------C-TKGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ----------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------- SAPs(SNPs) (3)
                    PROSITE -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: I:13-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                Exon 1.4c  PDB: I:105-176 UniProt: 137-208                              Exon 1.5a  PDB: I:177-222 UniProt: 209-254    Exon 1.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: I:375-432 (gaps) UniProt: 407-464          Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 1ant I  13 RDIPMNPMCIYRSPEKK-------------ATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNE-----AASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    22      |  -         -|       52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372    |    -|      392       402       412       422       432
                                           29            43                                                                                                                                                                                                                                                                                                                                           377   383

Chain L from PDB  Type:PROTEIN  Length:392
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:419
                                    55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455         
           ANT3_HUMAN    46 DIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d1antl_ L: A                 ntithrombin                                                                                                                                                                                                                                                                                                                                                                                            SCOP domains
               CATH domains 1antL02 L:14                 -224,L:321-377 Antithrombin, subunit I, domain 2                                                                                                                                      1antL01 L:225-320,L:378-430 Alpha-1-antitrypsin, domain 1                                       1antL02 L:14-224,L:321-377                               1antL01 L:225-320,          L:378-430                -- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ............-----------------....hhhhhhhhhhhhhhhhhhhhhhh....eeeee.hhhhhhhhhhhhhh...hhhhhhhhhh.........hhhhhhhhhhhhhhhhh.....eeeeeeeeeee.......hhhhhhhh....eeeeee.....hhhhhhhhhhhhhhhh..................eeeeeeeeeeee..........eeeeeee....eeeeeeeeee...eee.....eeeeeeee.....eeeeeee......hhhhhh..hhhhhhhhhh......eeee..eeeeeee..hhhhhhh...........................eeeeeeeeeee...eeeeeeeeeee.....----------...eeeeeee...eeeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) ------TF--C----------------------C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-----------GA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H------------ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P-------------T------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: L:14-104 (gaps) UniProt: 14-136 [INCOMPLETE]                               Exon 1.4c  PDB: L:105-176 UniProt: 137-208                              Exon 1.5a  PDB: L:177-222 UniProt: 209-254    Exon 1.6b  PDB: L:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: L:375-432 (gaps) UniProt: 407-464          Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 1ant L  14 DIPMNPMCIYRS-----------------ATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSL----------RPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    23 |       -        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393 |       -  |    413       423         
                                      25                43                                                                                                                                                                                                                                                                                                                                                             395        406

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (17, 17)

Asymmetric/Biological Unit(hide GO term definitions)

Chain I,L (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (4, 4)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (84, 161)

PROSITE Motifs (1, 2)

Exons (6, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (2, 4)

Pfam Domains (0, 0)

Gene Ontology (17, 17)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File